These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
799 related items for PubMed ID: 15226739
1. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch KP, Murphy DL, Hall FS, Uhl GR, Sora I. Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739 [Abstract] [Full Text] [Related]
2. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens. Mateo Y, Budygin EA, John CE, Banks ML, Jones SR. J Neurosci Methods; 2004 Dec 30; 140(1-2):183-7. PubMed ID: 15589348 [Abstract] [Full Text] [Related]
3. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice. Budygin EA, John CE, Mateo Y, Jones SR. J Neurosci; 2002 May 15; 22(10):RC222. PubMed ID: 12006604 [Abstract] [Full Text] [Related]
4. Molecular mechanisms underlying the rewarding effects of cocaine. Hall FS, Sora I, Drgonova J, Li XF, Goeb M, Uhl GR. Ann N Y Acad Sci; 2004 Oct 15; 1025():47-56. PubMed ID: 15542699 [Abstract] [Full Text] [Related]
5. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G. J Neurosci; 2001 May 01; 21(9):RC141: 1-4. PubMed ID: 11312315 [Abstract] [Full Text] [Related]
6. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, Lesch KP, Murphy DL, Uhl GR. Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):5300-5. PubMed ID: 11320258 [Abstract] [Full Text] [Related]
7. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. Morón JA, Brockington A, Wise RA, Rocha BA, Hope BT. J Neurosci; 2002 Jan 15; 22(2):389-95. PubMed ID: 11784783 [Abstract] [Full Text] [Related]
8. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM. J Neurosci Methods; 2004 Dec 30; 140(1-2):169-81. PubMed ID: 15589347 [Abstract] [Full Text] [Related]
9. Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. Stewart A, Davis GL, Gresch PJ, Katamish RM, Peart R, Rabil MJ, Gowrishankar R, Carroll FI, Hahn MK, Blakely RD. Neuropsychopharmacology; 2019 Apr 30; 44(5):994-1006. PubMed ID: 30578419 [Abstract] [Full Text] [Related]
10. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice. Rothman RB, Carroll FI, Morales M, Rowley DL, Rice KC, Dersch CM, Donovan DM. Synapse; 2002 May 30; 44(2):94-105. PubMed ID: 11891881 [Abstract] [Full Text] [Related]
11. 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Trigo JM, Renoir T, Lanfumey L, Hamon M, Lesch KP, Robledo P, Maldonado R. Biol Psychiatry; 2007 Sep 15; 62(6):669-79. PubMed ID: 17306775 [Abstract] [Full Text] [Related]
12. No role of the dopamine transporter in acute ethanol effects on striatal dopamine dynamics. Mathews TA, John CE, Lapa GB, Budygin EA, Jones SR. Synapse; 2006 Sep 15; 60(4):288-94. PubMed ID: 16786536 [Abstract] [Full Text] [Related]
13. Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice. Zhang Y, Schlussman SD, Ho A, Kreek MJ. Synapse; 2003 Dec 01; 50(3):191-9. PubMed ID: 14515336 [Abstract] [Full Text] [Related]
14. Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: evidence for differential regulation in caudate putamen and nucleus accumbens. Samuvel DJ, Jayanthi LD, Manohar S, Kaliyaperumal K, See RE, Ramamoorthy S. J Pharmacol Exp Ther; 2008 Apr 01; 325(1):293-301. PubMed ID: 18198344 [Abstract] [Full Text] [Related]
15. Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT1A receptor in the mouse striatum and prefrontal cortex. Hagino Y, Hall FS, Uhl GR, Sora I, Ikeda K. Neuropsychopharmacol Rep; 2021 Mar 01; 41(1):91-101. PubMed ID: 33547882 [Abstract] [Full Text] [Related]
16. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, Ching S, Quan N, Stephens RL, Hill ER, Nottoli T, Han DD, Gu HH. Proc Natl Acad Sci U S A; 2006 Jun 13; 103(24):9333-8. PubMed ID: 16754872 [Abstract] [Full Text] [Related]
17. Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi. Tarazi FI, Tomasini EC, Baldessarini RJ. Neurosci Lett; 1998 Sep 18; 254(1):21-4. PubMed ID: 9780082 [Abstract] [Full Text] [Related]
18. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Morice E, Denis C, Giros B, Nosten-Bertrand M. Eur J Neurosci; 2004 Jul 18; 20(1):120-6. PubMed ID: 15245485 [Abstract] [Full Text] [Related]
19. Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Mateo Y, Budygin EA, John CE, Jones SR. Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):372-7. PubMed ID: 14691264 [Abstract] [Full Text] [Related]
20. Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters. Hagino Y, Takamatsu Y, Yamamoto H, Iwamura T, Murphy DL, Uhl GR, Sora I, Ikeda K. Curr Neuropharmacol; 2011 Mar 06; 9(1):91-5. PubMed ID: 21886569 [Abstract] [Full Text] [Related] Page: [Next] [New Search]